The trademark Dermabiogen was filed by Laves-Arzneimittel GmbH, a corporation established under the laws of the Federal Republic of Germany (the "Applicant"). The application was published for oppositions on July 11, 2022, and received one opposition filed on October 10, 2022 by Abiogen Pharma S.p.A. on (a) Art. 8(4), (b) Likelihood of confusion, (c) Unfair advantage and detriment to distinctiveness or repute. the opponent was represented by Viganò, Jessica and proceedings were handled in English, and the oppositon was dismissed by the Euorpean Union Intellectual Property Office with decision issued October 10, 2022
The application was filed in German, and German was also language of all opposition proceedings (English was selected as the second language).
The Opposition with reference B 003180599 was refused according to Article 8(1)(b) EUTMR with decision issued on December 12, 2024 by the EUIPO.